VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹69 Cr | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr |
What is the latest Operating Profit of VENUS REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹69 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹54 Cr |
How is Operating Profit of VENUS REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | 14.99 | |
| Mar2025 | ₹60 Cr | -0.71 | |
| Mar2024 | ₹60 Cr | -3.36 | |
| Mar2023 | ₹62 Cr | 15.50 | |
| Mar2022 | ₹54 Cr | - | |
Compare Operating Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,779.3 Cr | -7.7% | -20.5% | 203.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -7.7% |
-20.5% |
203.2% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses